Bloomberg Announces Derivatives Swaps Trading Platform

washington-dc
Orders from Washington have prompted the development of SEFs for derivatives trading.

Bloomberg has announced the launch of ALLQ Derivatives, a fully integrated trading platform for over-the-counter (OTC) derivatives swaps that aids with regulatory compliance.

Vendor official say ALLQ Derivatives is the foundation for the development of a swap execution facility (SEF), allowing buy-side institutional investors to access indicative prices and execute directly with dealers on the Bloomberg Professional service.

"Bloomberg is the largest independent trading platform for OTC derivatives and we have been actively working with regulators to develop the mandatory clearing and post-trading reporting requirements," says Ben Macdonald, global head of Bloomberg's fixed-income business. "The challenge now is to get the market ready, when we don't know exactly what the regulations will entail. The development of the ALLQ Derivatives platform is a crucial step toward SEF-style trading and the support we are getting in the marketplace is strong."

Under the Dodd–Frank Act, those trading in credit default swaps and other derivatives must do so through SEFs. US regulators are currently finalizing the rules relating to this.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Systematic tools gain favor in fixed income

Automation is enabling systematic strategies in fixed income that were previously reserved for equities trading. The tech gap between the two may be closing, but differences remain.

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here